Anavex Life Sciences Corp (AVXL)

[jimmy667]

Potentially HUGE near-term catalyst for A2-73 development as well as stock price was recently illuminated by Mrplmr and Bourbon in this thread of posts:

Bourbon_on_my_cornflakes Thursday, 11/30/17 01:48:12 PM
Re: mrplmer post# 132419
Post #
132420
of 132518 Go
"Authority under FDASIA to grant accelerated approval based on intermediate clinical endpoints"

hmm, could insomnia prevention be an intermediate clinical endpoint for alz? you would know that in 3 months!

Take a moment to ponder the gravity of this particular point. Some have opined that the start of the trials will not be a stock moving event. Of course, these are expected. If they start before end of the year there may be some relief rally to the extent that delay was baked into the recent slide. However that is not the point!

The point is the unveiling of the Trial Designs together with the FDA agreed endpoints particularly the Alzheimer's P2/3 design and plan.

Now if the FDA agrees that there are intermediate endpoints that could be reached that would provide immediate and safe relief to Alzheimer's victims, such as relief from insomnia, agitation, mood and other symptomatic benefits short of the penultimate goal of preventing (or slowing) decline of cognition and other traditional and hard to reach endpoints what would the New FDA be mandated by the 21st Century Cures Act to do?

How would this speed the development of A2-73?

How might the Market react to this highly achievable intermediate approval scenario?

I know many of you have carried a heavy risk load for a long time. Hang in there the reward may come in the next three weeks.

Good Luck to all Honest Longs.

Truth as Beauty is its Own Reward!